Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCD in Relapsed/Refractory Multiple Myeloma (IFM/DFCI 2009 Follow-up)
NCT02244125Phase 2Completed
- Sponsor
- Institut Curie
- Start
- Apr 2014
- Primary completion
- Jan 2017
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
Phase 2, open-label trial of pomalidomide in multiple myeloma (MM), sponsored by Institut Curie. Started Apr 2014; status: completed.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02244125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244125.